China in Talks With Pfizer for Generic COVID Drug: Sources

China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's COVID-19 antiviral drug Paxlovid in China.
Reuters Health Information

source https://www.medscape.com/viewarticle/986604?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost